Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey

Journal of Clinical Microbiology

Volumn 42, Issue 6, 2004, Pages 2701-2706

  Hasdemir, Ufuk Over ^a,b   Chevalier, Jacqueline ^b   Nordmann, Patrice ^c   Pagès, Jean Marie ^b  

^a MARMARA UNIVERSITY   (Turkey)

^b AIX MARSEILLE UNIVERSITY   (France)

^c BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACRA PROTEIN; ACRAB PROTEIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; CARBON 14; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CHLORAMPHENICOL; HYBRID PROTEIN; IMIPENEM; MEMBRANE PROTEIN; MEROPENEM; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN A; OUTER MEMBRANE PROTEIN X; PHENYLALANINE ARGININE BETA NAPHTHYLAMIDE; PORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TOLC PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG TRANSPORT; HOSPITAL INFECTION; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; STRAIN DIFFERENCE; TURKEY (REPUBLIC);

BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CHLORAMPHENICOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI PROTEINS; HYDROLASES; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PORINS;

BACTERIA (MICROORGANISMS); KLEBSIELLA; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA;

EID: 2942615162     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.6.2701-2706.2004     Document Type: Article

References (29)

1. Alekshun, M. N., and S. B. Levy. 1999. The mar regulon: multiple resistance to antibiotics and other toxic chemicals. Trends Microbiol. 7:410-413.
2. Chevalier, J., J.-M. Pagès, A. Eyraud, and M. Malléa. 2000. Membrane permeability modifications are involved in antibiotic resistance in Klebsiella pneumoniae. Biochem. Biophys. Res. Commun. 274:496-499.
3. Dé, E., A. Basle, M. Jaquinod, N. Saint, M. Malléa, G. Molle, and J.-M. Pagès. 2001. A new mechanism of antibiotic resistance in Enterobacteriaceae induced by a structural modification of the major porin. Mol. Microbiol. 41:189-198.
4. Gayet, S., R. Chollet, G. Molle, J.-M. Pagès, and J. Chevalier. 2003. Modification of outer membrane protein profile and evidence suggesting an active drug pump in Enterobacter aerogenes clinical strains. Antimicrob. Agents Chemother. 47:1555-1559.
5. George, A. M. 1996. Multidrug resistance in enteric and other Gram-negative bacteria. FEMS Microbiol. Lett. 139:1-10.
6. Grkovic, S., M. H. Brown, and R. A. Skurray. 2001. Transcriptional regulation of multidrug efflux pumps in bacteria. Semin. Cell Dev. Biol. 12:225-237.
7. Gruteke, P., W. Goessens, J. Gils, P. Peerbooms, N. Lemmens-den Toom, M. Santen-Verheuvel, A. Belkum, and H. Verbrugh. 2003. Patterns of resistance associated with integrons, the extended-spectrum β-lactamase SHV-5 gene, and a multidrug efflux pump of Klebsiella pneumoniae causing a nosocomial outbreak. J. Clin. Microbiol. 41:1161-1166.
8. Gunseren, F., L. Mamikoglu, and S. Ozturk. 1999. A surveillance study of antimicrobial resistance of gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey. J. Antimicrob. Chemother. 43:373-378.
9. Hernández-Allés, S., S. Albertí, X. D. Alvarez, A. Doménech-Sánchez, L. Martínez-Martínez, J. Gil, J. M. Tomás, and V. J. Benedí. 1999. Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology 145: 673-679.
10. Jarlier, V., M. H. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
11. Koseoglu, O., S. Kocagoz, D. Gur, and M. Akova. 2001. Nosocomial bloodstream infections in a Turkish University hospital: study of gram-negative bacilli and their sensitivity patterns. Int. J. Antimicrob. Agents 17:477-478.
12. Levy, S. B. 2002. Active efflux, a common mechanism for biocide and antibiotic resistance. J. Appl. Microbiol. 92(Suppl.):65S-71S.
13. Lomovskaya, O., M. S. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, J. Blais, D. Cho, S. Chamberland, T. Renau, R. Leger, S. Hecker, W. Watkins, K. Hoshino, H. Ishida, and V. J. Lee. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105-116.
14. Malléa, M., J. Chevalier, C. Bornet, A. Eyraud, A. Davin-Regli, C. Bollet, and J.-M. Pagès. 1998. Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology 144:3003-3009.
15. Malléa, M., J. Chevalier, A. Eyraud, and J.-M. Pagès. 2002. Inhibitors of antibiotic efflux pump in resistant Enterobacter aerogenes strains. Biochem. Biophys. Res. Commun. 293:1370-1373.
16. Martinéz-Martinéz, L., A. Pascual, M. C. Conejo, I. García, P. Joyanes, A. Doménech-Sánchez, and V. J. Benedí. 2002. Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum β-lactamase production. Antimicrob. Agents Chemother. 46:3926-3932.
17. Mazzariol, A., Y. Tokue, T. M. Kanegawa, G. Cornaglia, and H. Nikaido. 2000. High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob. Agents Chemother. 44:3441-3443.
18. Mazzariol, A., J. Zuliani, G. Cornaglia, G. M. Rossolini, and R. Fontana. 2002. AcrAB efflux systems: expression and contribution to fluoroquinolone resistance in Klebsiella spp. Antimicrob. Agents Chemother. 12:3984-3986.
19. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution susceptibility tests for bacteria grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
20. Nikaido, H. 1998. Antibiotic resistance caused by gram-negative multidrug efflux pumps. Clin. Infect. Dis. 27(Suppl. 1):32S-41S.
21. Nikaido, H. 2001. Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin. Cell Dev. Biol. 12:215-223.
22. Nikaido, H. 1994. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264:382-388.
23. Over, U., D. Gur, S. Unal, G. H. Miller, and Aminoglycoside Resistance Study Group. 2001. The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey. Clin. Microbiol. Infect. 7:470-478.
24. Paulsen, I. T., M. H. Brown, and R. A. Skurray. 1996. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60:575-608.
25. Poole, K. 2003. Overcoming multidrug resistance in gram-negative bacteria. Curr. Opin. Investig. Drugs 4:128-139.
26. Pradel, E., and J.-M. Pagès. 2002. The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes. Antimicrob. Agents Chemother. 46:2640-2643.
27. Schneiders, T., S. G. Amyes, and S. B. Levy. 2003. Role of AcrR and RamA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. Antimicrob. Agents Chemother. 47:2831-2837.
28. Simonet, V., M. Malléa, D. Fourel, J. M. Bolla, and J.-M. Pagès. 1996. Crucial domains are conserved in Enterobacteriaceae porins. FEMS Microbiol. Lett. 136:91-97.
29. Stoorvogel, J., M. J. van Bussel, and J. A. van de Klundert. 1991. Biological characterization of an Enterobacter cloacae outer membrane protein (OmpX). J. Bacteriol. 173:161-167.